Emtract Ingest
API
EN
EN
DE
Dashboard
Regulations
Crawlers
Attributes
Topics
Home
/
Crawlers
/
German Federal Law
/
Verordnung zur Festlegung der nicht geringen Menge von Dopingmitteln
/
Edit regulation source
Edit regulation source
Source URL
Name
Reference number
Regulation
Tenth BImSchV
Tenth Product Safety Ordinance
Tenth Pension Adjustment Act
Eleventh Amendment to the Lastenausgleich Act
Ordinance on Emission Declarations
Explosion Protection Ordinance
Eleventh Pension Adjustment Act
Eleventh Pension Adjustment Regulation 1996
Major Accidents Ordinance
Lifts Ordinance
Twelfth Pension Adjustment Act
Twelfth Painting and Varnishing Trade Ordinance
Ordinance on Large Combustion Plants, Gas Turbine Plants and Internal Combustion Engine Plants
Thirteenth Roofing Minimum Wage Regulation
Thirteenth Pension Adjustment Act
14th Federal Immission Control Ordinance
Fourteenth Equalization of Burdens Amendment Act
Pressure Equipment Ordinance
Fourteenth Pension Adjustment Act
Fifteenth Product Safety Ordinance
Fifteenth Pension Adjustment Act
Sixteenth Act Amending the Equalization of Burdens Act
Traffic Noise Protection Ordinance
Sixteenth Pension Adjustment Act
First Remuneration Standardisation and Reorganisation Act
First Federal Immission Control Ordinance
1-DM Gold Coin Act
First Regulation Implementing the Federal Compensation Act
First Implementing Regulation to the Operating Regulations for Aviation Equipment
First Marriage and Family Law Reform Act
First Aircraft Noise Protection Ordinance
Low Voltage Ordinance
First Pension Adjustment Act 1958
First Explosives Ordinance
First Water Supply Security Ordinance
First Offshore Wind Energy Regulation
First Electoral Ordinance under the Co-Determination Act
Implementing Regulation (EU) 2019/296
Aarhus Regulation
Aarhus Regulation
Aerosol Containers Ordinance
Alternative Fuels Infrastructure Regulation
Alternative Fuels Infrastructure Regulation
Alternative Fuels Infrastructure Regulation
AIFM Sustainability Risks Delegated Regulation
Al Quoz Creative Zone Supreme Committee Resolution
Anti-Money Laundering Regulation
Federal Registration Data Transfer Regulation
CBAM Amendment Regulation
CBAM Simplification Regulation
Delegated Directive on Sustainability Factors in Product Governance
UCITS Sustainability Risks Delegated Directive
Plastic Food Contact Materials Regulation
Conflict Minerals Regulation
Construction Products AVCP Delegated Regulation
Consumer Rights Directive
Corporate Sustainability Omnibus Directive
Corporate Sustainability Reporting and Due Diligence Amending Directive
Construction Products Regulation
Construction Products Regulation
Consumer Rights Directive
Critical Raw Materials Act
Critical Raw Materials Act
Corporate Sustainability Due Diligence Directive
Corporate Sustainability Reporting Directive
DECCA Law
Dubai International Award for Best Practices to Improve the Living Environment
Sustainability Reporting Amending Directive
Dubai OHS-E Manual
Dubai Public Health Law
Energy Efficiency Directive
Energy Efficiency Directive
Environmental Impact Assessment Directive
Environmental Impact Assessment Directive
Railway Crossing Costs Regulation
Environmental Liability Directive
End-of-Life Vehicles Directive
End-of-Life Vehicles Directive
Energy Taxation Directive
Energy Taxation Directive
Pay Transparency Act
Environmental Crime Directive
Environmental Crime Directive
Environmental Information Directive
Environmental Information Directive
Environmental Liability Directive
Energy Performance of Buildings Directive
Energy Performance of Buildings Directive
First Pension Adjustment Regulation
First Regulation Implementing the Federal Restitution Act
European Single Access Point Regulation
Ecodesign for Sustainable Products Regulation
Ecodesign for Sustainable Products Regulation
Sustainability Risks Delegated Regulation
Sustainability and GHG Criteria Implementing Regulation
Plastic Food Contact Materials Regulation
Net-Zero Technologies Public Procurement Sustainability Regulation
EU Deforestation Regulation
EU Deforestation Regulation
EU Ecolabel Regulation
EU Ecolabel Regulation
Food Chain Risk Assessment Transparency Regulation
European Green Bonds Regulation
Plastic Materials and Articles Regulation
European Accessibility Act
European Accessibility Act
European Climate Law
F-Gas Regulation
F-Gas Regulation
Food Information Regulation
Food Information Regulation
Forest Biomass Sustainability Criteria Guidance
Farm Sustainability Data Network Implementing Regulation
FSDN Implementing Regulation
FSDN Delegated Regulation
FSDN Financing Implementing Regulation
Farm Sustainability Data Network Regulation
GEIG
Green Claims Directive
Green Claims Directive
Empowering Consumers for the Green Transition Directive
Empowering Consumers for the Green Transition Directive
IDD Sustainability Delegated Regulation
Industrial Emissions Directive
Supply Chain Due Diligence Act
Supply Chain Due Diligence Act
Low Carbon Benchmarks Regulation
MiCA Sustainability Indicators Regulation
Conflict Minerals Implementation Act
Marine Strategy Framework Directive
Marine Strategy Framework Directive
Non-Financial Reporting Directive
Nutrition and Health Claims Regulation
Nutrition and Health Claims Regulation
Net-Zero Industry Act
Net-Zero Industry Act
Packaging and Packaging Waste Directive
Packaging and Packaging Waste Directive
Packaging and Packaging Waste Regulation
Packaging and Packaging Waste Regulation
Preventive Systems Manual
Preventive Systems Manual
Preventive Systems Manual
Preventive Systems Manual
REACH Regulation
Renewable Energy Directive II
Renewable Energy Directive II
Renewable Energy Directive III
Renewable Energy Directive III
Right to Repair Directive
Right to Repair Directive
RoHS Directive (restriction of hazardous substances in EEE)
Securitisation Principal Adverse Impacts RTS
Sustainable Finance Disclosure Regulation
Solvency II Amending Directive
Single-Use Plastics Directive
Single-Use Plastics Directive
MiFID II Delegated Regulation on Sustainability Preferences
Waste Framework Directive Amendment
Toy Safety Directive (TSD)
Unfair Commercial Practices Directive
Unfair Commercial Practices Directive
Union Customs Code
Urban Mobility Data Implementing Regulation
Agricultural Organisations and Supply Chains Regulation
Waste Framework Directive Amendment
Water Framework Directive
Waste Electrical and Electronic Equipment Directive
WEEE Directive
Whistleblower Protection Directive
Whistleblower Protection Directive
First Implementing Regulation on Equalization Law in Saarland
flgdv_1
First SGB XI Amendment Act
gkvnog_1
Tenth Amendment Regulation to the Road Haulage Act
2023/1115
Tenth Federal War Victims' Pensions Benefits Adjustment Act
geb_udearbbv_10
First Interest Rate Increase Regulation for Housing Assistance Loans
Delegated Regulation on voluntary post-issuance disclosures for sustainable bonds
Regulation crawler
Dubai Sustainability
ELI Poland Sustainability
EU Regulations
EUR-Lex Crawl
EUR-Lex Sustainability Crawl
FramesCube Manual Requests
German Federal Law
Italy Sustainability
Manual
Poland Sustainability
Schokolade
UK Sustainability
Publish date
Updated date
Language
Markdown
# Verordnung zur Festlegung der nicht geringen Menge von Dopingmitteln ### (XXXX) Die nicht geringe Menge der Stoffe im Sinne des § 2 Absatz 3 des Anti-Doping-Gesetzes ist die in der Anlage bestimmte Menge. Die nicht geringe Menge wird für die freie Verbindung des betreffenden Stoffes angegeben. ### Anlage (Fundstelle: BGBl. 2023 I Nr. 67, S. 5 - 10) - **I.** **Anabole Stoffe** - **1.** **Anabol-androgene Steroide** | | nicht geringe Menge | | --- | --- | | Androst-4-en-3,11,17-trion | 3 000 mg | | Androstanolon, synonym Dihydrotestosteron | 1 500 mg | | 1-Androstendiol | 3 000 mg | | Androstendiol | 3 000 mg | | 1-Androstendion | 3 000 mg | | Androstendion | 3 000 mg | | 1-Androsteron | 3 000 mg | | Bolasteron | 100 mg | | Boldenon | 1 000 mg | | Boldion | 3 000 mg | | Calusteron | 100 mg | | Clostebol | | | – parenterale Darreichungsformen | 80 mg | | – andere Darreichungsformen | 900 mg | | Danazol | 3 000 mg | | Dehydrochlormethyltestosteron | 100 mg | | Desoxymethyltestosteron | 100 mg | | Drostanolon | 1 015 mg | | Epistan | 100 mg | | Ethylestrenol | 450 mg | | Fluoxymesteron | 100 mg | | Formebolon | 100 mg | | Furazabol | 100 mg | | Gestrinon | 45 mg | | 4-Hydroxytestosteron | 1 500 mg | | Mestanolon | 100 mg | | Mesterolon | 1 500 mg | | Metandienon | 100 mg | | Metenolon | | | – parenterale Darreichungsformen | 150 mg | | – andere Darreichungsformen | 1 500 mg | | Methandriol | 100 mg | | Methasteron | 100 mg | | Methyldienolon | 45 mg | | Methyl-1-testosteron | 100 mg | | Methylnortestosteron | 100 mg | | Methylstenbolon | 100 mg | | Methyltestosteron | 100 mg | | Metribolon, synonym Methyltrienolon | 45 mg | | Miboleron | 100 mg | | Nandrolon | 150 mg | | 19-Norandrostendion | 3 000 mg | | Norboleton | 450 mg | | Norclostebol | 1 500 mg | | Norethandrolon | 450 mg | | Oxabolon | 75 mg | | Oxandrolon | 100 mg | | Oxymesteron | 100 mg | | Oxymetholon | 100 mg | | Prasteron, synonym Dehydroepiandrosteron (DHEA) | | | – parenterale Darreichungsformen | 144 mg | | – andere Darreichungsformen | 3 000 mg | | Prostanozol | 1 500 mg | | Quinbolon | 1 500 mg | | Stanozolol | 100 mg | | Stenbolon | 1 500 mg | | 1-Testosteron | 1 500 mg | | Testosteron | | | – transdermale oder orale Darreichungsformen | 1 500 mg | | – andere Darreichungsformen | 632 mg | | Tetrahydrogestrinon | 45 mg | | Tibolon | 225 mg | | Trenbolon | 150 mg | | Andere mit anabol-androgenen Steroiden verwandte Stoffe | | | – mit 17alpha-Methyl-Struktur | 100 mg | | – mit anderen Strukturen | 3 000 mg | - **2.** **Andere anabole Stoffe** | | nicht geringe Menge | | --- | --- | | Clenbuterol | 5,4 mg | | Osilodrostat | 5 400 mg | | Selektive Androgen-Rezeptor-Modulatoren (SARMs) | 540 mg | | Zum Beispiel: | | | Andarin (S-4) | | | Ligandrol (LGD-4033, VK 5211) | | | Ostarin, synonym Enobosarm (S-22, MK-2866) | | | RAD-140, synonym Testolon | | | S-23 | | | YK-11 | | | Zeranol | 4,5 mg | | Zilpaterol | 4,5 mg | - **II.** **Peptidhormone, Wachstumsfaktoren, verwandte Stoffe und Mimetika** - **1.** **Erythropoese stimulierende Stoffe** | | nicht geringe Menge | | --- | --- | | Erythropoetin human (EPO) | 24 000 IE | | Epoetin alfa, beta, delta, omega, theta, zeta und analoge rekombinante humane Erythropoetine | | | Darbepoetin alfa (dEPO) | 120 µg | | Methoxy-Polyethylenglycol-Epoetin beta, synonym PEG-Epoetin beta, Continuous Erythropoiesis Receptor Activator (CERA) | 90 µg | | Peginesatid, synonym Hematid | 5 mg | | Hypoxie-induzierbarer-Faktor (HIF)-Aktivatoren | 15 600 mg | | Zum Beispiel: | | | Daprodustat (GSK1278863) | | | Molidustat | | | Roxadustat (FG-4592) | | | Vadadustat (AKB-6548) | | - **2.** **Peptidhormone und ihre Releasingfaktoren** - **2.1.** **Choriongonadotropin (CG) und Luteinisierendes Hormon (LH) sowie ihre Releasingfaktoren** | | nicht geringe Menge | | --- | --- | | Buserelin | 168 mg | | Choriongonadotropin (HCG) | 65 000 IE | | Choriongonadotropin alfa | 750 µg | | Deslorelin | 4,5 mg | | Gonadorelin | 40 mg | | Goserelin | 10,8 mg | | Leuprorelin | 30 mg | | Lutropin alfa | 2 250 IE | | Nafarelin | 24 mg | | Triptorelin | | | – Injektionslösung | 8,6 mg | - **2.2.** **Corticotropine** | | nicht geringe Menge | | --- | --- | | Corticotropin | 1 200 IE | | Tetracosactid | | | – retardierte parenterale Darreichungsformen | 12 mg | | – andere parenterale Darreichungsformen | 3 mg | - **2.3.** **Wachstumshormon (-Analoga und -Fragmente), Releasingfaktoren und Releasingpeptide** | | nicht geringe Menge | | --- | --- | | Lonapegsomatropin | 673 mg | | Somapacitan | 104 mg | | Somatrogon | 600 mg | | Somatropin, synonym Wachstumshormon human, Growth Hormone (GH) | 16 mg | | Somatrem, synonym Somatotropin (methionyl), human | 16 mg | | Wachstumshormon-Fragmente | 16 mg | | Zum Beispiel: | | | AOD-9604 | | | hGH-Fragment 176-191 | | - **2.4.** **Wachstumshormon Releasingfaktoren** | | nicht geringe Menge | | --- | --- | | Wachstumshormon-Releasing-Hormon, synonym Growth Hormone Releasing Hormones (GHRH) | 180 mg | | Zum Beispiel: | | | Sermorelin | | | Somatorelin | | | Tesamorelin | | | mod-GRF | | | CJC-1295 | | | Wachstumshormon-Sekretagoge (GHS) und ihre Mimetika | 150 mg | | Zum Beispiel: | | | Anamorelin | | | Ipamorelin | | | Lenomorelin, synonym Ghrelin | | | Macimorelin | | | Ibutamoren, synonym MK-677, Nutrabol | | | Tabimorelin | | | Peptide mit gleicher Wirkung wie Wachstumshormon Releasingfaktoren, synonym Growth Hormone Releasing Peptides (GHRP) | 1,5 mg | | Zum Beispiel: | | | GHRP-2, synonym Pralmorelin | | | GHRP-2-Gly | | | GHRP-6 | | | GHRP-6-Gly | | | Hexarelin | | - **3.** **Wachstumsfaktoren und Wachstumsfaktor-Modulatoren** | | nicht geringe Menge | | --- | --- | | Mecasermin, synonym Insulin-ähnlicher Wachstumsfaktor 1, Insulin-like Growth Factor -1 (IGF-1) | 60 mg | | IGF-1 Analoga | 3 mg | | Mechano Growth Factor (MGF) und MGF-Varianten | 3 mg | | Thymosin-beta-4 und seine Derivate | 100 mg | | Zum Beispiel: | | | TB -500 | | - **III.** **Hormon- und Stoffwechsel-Modulatoren** - **1.** **Aromatasehemmer** | | nicht geringe Menge | | --- | --- | | Aminoglutethimid | 30 000 mg | | Anastrozol | 90 mg | | Androsta-3,5-dien-7,17-dion, synonym Arimistan | 4 500 mg | | Androsta-1,4,6-trien-3,17-dion, synonym Androstatriendion | 3 000 mg | | 4-Androsten-3,6,17-trion, synonym 6-oxo | 6 000 mg | | Exemestan | 2 250 mg | | Formestan | 600 mg | | Letrozol | 225 mg | | Testolacton | 90 000 mg | - **2.** **Antiestrogene Stoffe** | | nicht geringe Menge | | --- | --- | | Clomifen | 1 500 mg | | Cyclofenil | 4 200 mg | | Fulvestrant | 2 000 mg | | Raloxifen | 5 400 mg | | Tamoxifen | 3 600 mg | | Toremifen | 5 400 mg | - **3.** **Myostatinfunktionen verändernde Stoffe** | | nicht geringe Menge | | --- | --- | | Follistatin und seine Derivate | 450 mg | | Stamulumab | 450 mg | - **4.** **Stoffwechsel-Modulatoren** | | nicht geringe Menge | | --- | --- | | Insuline | 1 800 IE | | PPARδ (Peroxisome Proliferator Activated Receptor Delta)-Agonisten, synonym PPAR-delta-Agonisten | 225 mg | | Zum Beispiel: | | | GW501516, synonym GW1516, Cardarin, Endurobolon | | | AMPK (PPARδ–AMP-activated protein kinase)-Axis-Agonisten | 7 000 mg | | Zum Beispiel: | | | AICAR | | | Meldonium | 42 000 mg | | SR9009, synonym Stenabolic | 75 mg |
Cancel
Delete this source